BEONE MEDICINES LTD.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|
| Revenue | $238.4M | $1.1M | $8.8M | $13.0M |
| Cost of Revenue | $5.0M | $0 | — | — |
| Gross Profit | $233.4M | $1.1M | — | — |
| Gross Margin | 97.9% | 100.0% | — | — |
| Operating Expenses | ||||
| Research & Development | $269.0M | $98.0M | $58.3M | $21.9M |
| SG&A Expense | $62.6M | $20.1M | $7.3M | $6.9M |
| Operating Income | $-98.5M | $-117.1M | $-56.7M | $-15.8M |
| Operating Margin | -41.3% | -10,940.2% | -643.7% | -120.9% |
| Interest Expense | — | — | — | — |
| Pretax Income | $-91.1M | $-119.2M | $-57.1M | $-18.5M |
| Income Tax Expense | $2.2M | $54.0K | $0 | $0 |
| Net Income | $-93.1M | $-119.2M | $-57.1M | $-18.3M |
| Net Margin | -39.1% | -11,141.8% | -647.7% | -140.2% |
| EPS (Basic) | $-0.17 | $-0.30 | $-0.52 | $-0.18 |
| EPS (Diluted) | $-0.17 | $-0.30 | $-0.52 | $-0.18 |
| Shares Outstanding (Basic) | 592.1M | 515.8M | 116.2M | — |
| Shares Outstanding (Diluted) | 592.1M | 515.8M | 116.2M | — |
| Dividends Per Share | — | — | — | — |